Orthocon
About:
ORTHOCON is a medical therapeutics company developing absorbable products for orthopaedic and spine surgeries.
Website: http://www.orthocon.com
Twitter/X: abyrx
Top Investors: Canaan Partners, BB Biotech Ventures, ProQuest Investments
Description:
ORTHOCON is a medical therapeutics company developing innovative absorbable products for orthopaedic and spine surgeries.
Total Funding Amount:
$47.5M
Estimated Revenue Range:
$10M to $50M
Headquarters Location:
New Brunswick, New Jersey, United States
Founded Date:
2003-01-01
Founders:
Arthur Alfaro
Number of Employees:
11-50
Last Funding Date:
2009-12-31
IPO Status:
Private
Industries:
© 2025 bioDAO.ai